Cargando…
Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization
PURPOSE: Amphotericin B (AmB) is an effective anti-fungal and anti-leishmanial agent. However, AmB has low oral bioavailability (0.3%) and adverse effects (e.g., nephrotoxicity). The objectives of this study were to improve the oral bioavailability by entrapping AmB in pegylated (PEG) poly lactide c...
Autores principales: | AL-Quadeib, Bushra T., Radwan, Mahasen A., Siller, Lidija, Horrocks, Benjamin, Wright, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475820/ https://www.ncbi.nlm.nih.gov/pubmed/26106277 http://dx.doi.org/10.1016/j.jsps.2014.11.004 |
Ejemplares similares
-
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats
por: Radwan, Mahasen A., et al.
Publicado: (2017) -
Stealth Coating of Nanoparticles in Drug-Delivery Systems
por: Fam, See Yee, et al.
Publicado: (2020) -
Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments
por: Maghrabia, Amir, et al.
Publicado: (2021) -
Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets: In-vitro and ex-vivo studies
por: Alagili, Modhi F., et al.
Publicado: (2023) -
Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro
por: Vieira, Débora B, et al.
Publicado: (2008)